SNX22 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.243600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.867800E-01
Normal-vs-Stage2
4.227400E-01
Normal-vs-Stage3
4.349400E-01
Normal-vs-Stage4
3.843800E-01
Stage1-vs-Stage2
3.734400E-02
Stage1-vs-Stage3
2.008200E-01
Stage1-vs-Stage4
8.872400E-01
Stage2-vs-Stage3
8.650400E-01
Stage2-vs-Stage4
5.217100E-03
Stage3-vs-Stage4
2.900200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.272000E-01
Normal-vs-AfricanAmerican
4.395400E-01
Normal-vs-Asian
3.965600E-01
Caucasian-vs-AfricanAmerican
5.474000E-01
Caucasian-vs-Asian
1.077440E-01
AfricanAmerican-vs-Asian
1.022160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.157000E-01
Normal-vs-Female
4.364800E-01
Male-vs-Female
2.510600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.821200E-01
Normal-vs-Age(41-60Yrs)
4.173200E-01
Normal-vs-Age(61-80Yrs)
4.278600E-01
Normal-vs-Age(81-100Yrs)
4.495800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.115800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.114000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.820400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.161400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.384600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.369400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.297400E-01
Normal-vs-Daily Drinker
4.508800E-01
Normal-vs-Weekly Drinker
3.953200E-01
Normal-vs-Occasional Drinker
4.168000E-01
Normal-vs-Social Drinker
3.908800E-01
Non Drinker-vs-Daily Drinker
6.057800E-01
Non Drinker-vs-Weekly Drinker
2.169000E-01
Non Drinker-vs-Occasional Drinker
6.565200E-01
Non Drinker-vs-Social Drinker
1.546750E-01
Daily Drinker-vs-Weekly Drinker
9.042000E-02
Daily Drinker-vs-Occasional Drinker
3.051800E-01
Daily Drinker-vs-Social Drinker
6.398000E-02
Weekly Drinker-vs-Occasional Drinker
1.512620E-01
Weekly Drinker-vs-Social Drinker
7.504200E-01
Occasional Drinker-vs-Social Drinker
6.907900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.319800E-01
Normal-vs-Grade 2
6.735800E-01
Normal-vs-Grade 3
9.487600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.633400E-01
Grade 1-vs-Grade 3
4.746400E-02
Grade 1-vs-Grade 4
6.319800E-01
Grade 2-vs-Grade 3
2.742800E-03
Grade 2-vs-Grade 4
6.735800E-01
Grade 3-vs-Grade 4
9.487600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.436800E-01
Normal-vs-NonDiabetic
4.122600E-01
Diabetic-vs-NonDiabetic
2.068200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.882000E-01
Normal-vs-NoPancreatitis
4.242800E-01
Pancreatitis-vs-NoPancreatitis
7.603100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.338800E-01
Normal-vs-N1
4.196600E-01
N0-vs-N1
5.424400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.585800E-01
Normal-vs-TP53-NonMutant
4.262800E-01
TP53-Mutant-vs-TP53-NonMutant
4.201500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
